Evidence map›Paper›PMID 37370278›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Screening of

Jürgen Rödel, Yvonne Pfeifer, Martin A Fischer, Birgit Edel, Sylvia Stoll, Wolfgang Pfister, Bettina Löffler

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Genomic Characterization of a Rare K30-ST198 HypervirulentInternational journal of molecular sciences · 2025
    Article
  3. Article
  4. HypervirulentPathogens & immunity · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jürgen RödelInstitute of Medical Microbiology, Jena University Hospital, Friedrich Schiller University, 07747 Jena, Germany.
Yvonne PfeiferDivision Nosocomial Pathogens and Antibiotic Resistance, Department of Infectious Diseases, Robert Koch Institute, 38855 Wernigerode, Germany.
Martin A FischerDivision Nosocomial Pathogens and Antibiotic Resistance, Department of Infectious Diseases, Robert Koch Institute, 38855 Wernigerode, Germany.ORCID 0000-0002-9319-3862
Birgit EdelInstitute of Medical Microbiology, Jena University Hospital, Friedrich Schiller University, 07747 Jena, Germany.
Sylvia StollInstitute of Medical Microbiology, Jena University Hospital, Friedrich Schiller University, 07747 Jena, Germany.
Wolfgang PfisterDepartment of Hospital Hygiene, Sophien-und Hufeland-Klinikum, 99425 Weimar, Germany.
Bettina LöfflerInstitute of Medical Microbiology, Jena University Hospital, Friedrich Schiller University, 07747 Jena, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The acquisition of hypervirulence-associated genes by carbapenemase-producing

Indexed as

carbapenemaseshypervirulenceKlebsiella pneumoniaeLAMP

Identifiers

PMID37370278
PMCPMC10294845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.